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Edeines are atypical cationic peptides produced by
Brevibacillus brevis Vm4 with broad-spectrum anti-
microbial activity. These linear nonribosomal pep-
tides bind to the 30S ribosomal subunit and block
t-RNA binding to the P-site. To identify the mecha-
nism of high-level self-resistance in the producing
organism, theB. brevis Vm4 genomewas sequenced
and the edeine biosynthetic cluster discovered. A
potential edeine-modifying enzyme, EdeQ, showed
similarity to spermidine N-acetyltransferases. EdeQ
was purified and shown to convert edeine to
N-acetyledeine, which is inactive against cells in vivo
and against cell-free extracts. Unexpectedly, tandem
mass spectroscopy and nuclearmagnetic resonance
demonstrate that N-acylation occurs on the free
amine of the internal diaminopropionic acid rather
than the N-terminal spermidine polyamine. Acetyla-
tion of edeine by EdeQ abolishes its ability to inhibit
translation, thus conferring resistance to the antibi-
otic in the producing organism.
INTRODUCTION
Edeines are a group of closely related linear peptides produced
by the soil bacterium Brevibacillus brevis Vm4 that contain
several unusual amino acids and are cationic at physiologic
pH. Initially discovered in 1959, these peptides have been
reported to be active against a wide variety of organisms,
including both gram-positive and gram-negative bacteria, fungi,
and cancer cell lines (Czajgucki et al., 2006; Hill et al., 1994). The
producing organism was originally called Bacillus brevis Vm4,
but was reclassified as Brevibacillus brevis Vm4 in 1996 (Shida
et al., 1996).
The mode of action of edeines is widely described as con-
centration-dependent. At low concentrations (<15 mg/ml),
edeines are bacteriostatic and inhibit DNA synthesis while pro-
tein synthesis is unaffected (Kurylo-Borowska and Szer, 1972).
On the other hand, at high concentrations (>150 mg/ml) they
become universal inhibitors of translation and exhibit bacteri-
cidal activity, a highly desirable therapeutic trait (Cozzarelli,Chemistry & Biology 20, 981977; Dinos et al., 2004). Edeines have been widely used
as probes for the study of translation and ribosome activity
(Dinos et al., 2004; Pioletti et al., 2001; Szaflarski et al., 2008).
Specifically, edeines block translation by preventing translation
initiation by inhibiting the binding of fMet-tRNA to the P site
of 30S ribosomes (Dinos et al., 2004). Despite their interesting
antimicrobial effects, the use of edeines as drugs has not been
seriously considered due to reports of high toxicity in animal
models and resulting poor therapeutic index (Czajgucki et al.,
2007). Given the increase of resistance to all other antibiotics
in clinical use, the reevaluation of effective and interesting antibi-
otics such as the edeines is important and worthy of exploration.
Edeines are pentapeptides that have a highly unusual back-
bone, which includes four nonproteinogenic amino acids and
an N-terminal polyamine cap (Figure 1). All edeines contain
core b-serine, 2,3-diaminopropanoic acid (DAPA), 2,6-diamino-
7-hydroxyazelaic acid (DAHAA; unique to edeines), and glycine
residues. Edeine A also contains a C-terminal b-tyrosine and
an N-terminal spermidine; other variants are known and are
distinguished based on the identity of the C-terminal amino
acid (either b-tyrosine or a b-phenylalanine) and the N-terminal
polyamine (either spermidine or guanylspermidine). Each edeine
can exist as an a- or b-isomer, depending on whether the
b-serine is linked to 2,3-diaminopropanoic acid by the a- or
b-amino group of the latter. In all cases, only the a-isomer, called
edeine A1 or edeine B1, respectively, have been reported to be
active antibiotics (Czajgucki et al., 2006; Czerwinski et al., 1983;
Hettinger and Craig, 1970).
B. brevis Vm4 produces a mixture of edeines A1, A2, B1, and
B2, but little is known about their biosynthesis. Considering the
peptide backbone and nonproteinogenic components, edeines
are most likely synthesized by nonribosomal peptide synthe-
tases (NRPSs). This is supported by studies that showed that
multienzyme complexes are involved in edeine production (Kur-
ylo-Borowska and Sedkowska, 1974). An understanding of
edeine biosynthesis is valuable because it would provide signif-
icant insight into the mechanisms of unusual amino acid
synthesis.
Reports of resistance to edeine are limited because it has
never been used as a drug. In some cases, edeine-resistant
strains have been constructed or identified in the laboratory
(Grilo and Klingmu¨ller, 1974; Herrera et al., 1984a). In the
case of Saccharomyces cerevisiae, resistance was shown
even in cell-free systems and ascribed to a mutant ribosomal
protein (Herrera et al., 1984b, 1986). This is not the case in B.3–990, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 983
Figure 1. Structures of Edeines A, B, D, and F
Two isomers of each type of edeine are known; those inwhich b-serine is linked to the a-amino group of DAPA are biologically active (isomer 1), and those inwhich
the b-serine is linked to the b-amino group of DAPA are inactive (isomer 2). Edeine nomenclature requires statement of the type of edeine (A, B, D, or F, depending
on the structural subunits) as well as the isomer (1 or 2, depending on the linkage of b-serine to the a- or b-amino group of DAPA). For example, the active edeine
A isomer 1 can be abbreviated to edeine A1. DAPA, 2,3-diaminopropionic acid; DAHAA, 2,6-diamino-7-hydroxyazaleic acid.
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highly resistant to exogenous edeine, purified ribosomes were
reported to be sensitive to edeine (Kurylo-Borowska and
Szer, 1976). In Neurospora crassa, the most likely cause of
resistance was stated to be altered uptake because cell-free
extracts were sensitive to edeine (Wagenmann et al., 1974).
Efflux of edeine is likely important in B. brevis Vm4 to both
export the antibiotic and to reduce intracellular concentra-
tions to avoid toxicity. No active edeines can be detected in
B. brevis Vm4 lysates, even during maximal edeine production
(Kurylo-Borowska and Szer, 1976). However, an inactive form
of edeine was detected associated with DNA/membrane
complexes in producer cells during maximal edeine synthesis;
mild treatment with alkali released active edeine B from this
material (Kurylo-Borowska and Szer, 1976). Each of these
reports were limited by the techniques available at the time
of study and do not give a full mechanistic understanding of
edeine resistance.
In this study, we report the identification and characterization
of the edeine biosynthetic cluster in B. brevis Vm4. The only
gene in the cluster located on the opposite strand, edeQ, was
investigated and its product demonstrated to be a resistance
enzyme, which acts by acetylating the a-amino group of
the 2,3-diaminopropionic acid residue of edeine a-isomers.
The modified compound, N-acetyledeine, shows no inhibition
of translation during in vitro translation experiments, demon-
strating that it has been inactivated by N-acylation thereby
revealing a molecular mechanism of self-resistance.984 Chemistry & Biology 20, 983–990, August 22, 2013 ª2013 ElseviRESULTS AND DISCUSSION
Identification and Bioinformatics Analysis of the Edeine
Biosynthetic Gene Cluster
A draft genome of B. brevis Vm4 was constructed using Roche
454 sequencing, which provided 22-fold coverage and 135 Mb
of sequence on 104 contigs. Analysis of the 16S rRNA sequence
using NCBI’s Basic Local Alignment Search Tool (BLAST) indi-
cated 99% identity to B. brevis, as expected.
Edeines are cationic peptides, and evidence that they are syn-
thesized in ribosome-free cell extracts (Borowska and Tatum,
1966) suggests that they are formed on NRPSs. Each NRPS
requires domains for adenylation, thiolation and peptide carrier
protein (PCP), and condensation. Because edeine is a penta-
peptide, a cluster with five NRPS genes was expected. To find
the edeine (ede) biosynthetic cluster, the genome was therefore
mined for NRPS genes using BLAST. The search concluded
with five gene clusters, two of which did not contain enough
adenylation domains to be capable of producing pentapeptides.
Of the remaining clusters, two corresponded to other peptide
antibiotics produced by B. brevis Vm4, namely linear gramicidin
and tyrocidine. Therefore, by process of elimination, the remain-
ing 45.1 kb cluster containing 17 open reading frames (ORFs)
bounded by tRNA genes became the most likely candidate for
edeine biosynthesis (Figure 2).
Further analysis of the putative cluster by the AntiSMASH
pipeline further analyzed the polyketide synthetase (PKS) and
NRPS genes within the cluster (Medema et al., 2011). Theer Ltd All rights reserved
Figure 2. Scale Map of the Edeine Biosyn-
thetic Gene Cluster from B. brevis Vm4
See also Table S1.
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one hybrid PKS-NRPS (edeI), and two PKS/NRPS-like proteins,
which contain PCP domains but lack other domains (edeG and
edeJ). Because there are more domains than expected for
pure peptide assembly, some may be inactive or serve other
functions. The presence of an epimerization domain in EdeP
indicates that this NRPS module likely acts on DAHAA because
it is the only amino acid with a D-configuration. Epimerization
domains are required for the synthesis of D-amino acids because
they are not typically found in microbial producers (Fischbach
and Walsh, 2006).
To predict the function of the remaining genes in the cluster,
predicted protein sequences encoded by each of the ORFs
were analyzed with BLAST (Table S1 available online). Surpris-
ingly, this analysis revealed that two organisms (B. brevis
NBRC 100599 and Brevibacillus sp. BC25) encode highly
similar clusters, suggesting that these strains are also capable
of producing edeines, although they have not been documented
to do so. In most cases, B. brevis NBRC 100599 was more
similar to B. brevis Vm4, with identity scores ranging from 95%
to 100%.
Edeines are secreted into the media and so the biosynthetic
cluster was expected to encode an exporter. This is predicted
to be EdeA, which has similarity to peptide transporter family
proteins. Most of the other genes of the cluster are expected
to encode biosynthetic enzymes for the production of the
unusual amino acid derivatives that occur in edeines. For
example, putative proteins EdeC and EdeD have similarity to
SbnA and SbnB, which have been shown to be required for the
synthesis of DAPA in Staphylococcus aureus (Beasley et al.,
2011); therefore, they likely function similarly in B. brevis to
create DAPA. Previous work on the biosynthesis of edeines
suggests that b-tyrosine is produced by an unusual tyrosine
2,3-aminomutase (designated here as BbTAM; Parry and
Kurylo-Borowska, 1980). In the putative edeine cluster, edeO
is the only ORF with similarity to aminomutases. The EdeO
sequence contains conserved domains with the radical SAM
superfamily, Fe-S clusters, and a number of lysine-2,3-amino-
mutase-related families (Marchler-Bauer et al., 2011). The
edeM ORF has conserved domains suggesting that it is a pyri-
doxal 50-phosphate (PLP)-dependent aspartate aminotrans-
ferase (Marchler-Bauer et al., 2011). Because edeine A requires
both b-tyrosine and b-serine, edeO and edeM likely provideChemistry & Biology 20, 983–990, August 22, 2013the aminomutase activity required to
generate the b-amino acids from tyrosine
and serine. The unusual amino acid deriv-
ative DAHAA is unique to edeines and so
no predictions exist for its biosynthesis at
this time.
The edeQ gene was of particular inter-
est because its 34% amino acid identity
to spermidine acetyltransferases sug-gested that it could be involved in edeine modification that
potentially confers a mechanism of resistance. Acetylated
edeines have not been described previously, despite substantial
work documenting different monomers and isomers (Figure 1).
None of the proteins with high similarity to EdeQ are functionally
characterized, so we sought to fully assess the biochemistry of
this protein.
Characterization of EdeQ and Its Product,
N-Acetyledeine
Due to its similarity to spermidine acetyltransferases, EdeQ was
initially hypothesized to be a resistance enzyme that could
inactivate edeine A via acetylation of the spermidine moiety.
Overexpressed EdeQ was soluble, and purification typically
yielded around 25 mg of EdeQ per liter of culture. To determine
the function of EdeQ, the enzyme was reacted with purified
edeine A in the presence of acetyl-CoA. After incubation with
EdeQ, analysis by liquid chromatography/mass spectroscopy
(LC/MS) showed an ion was with m/z = 797.3, consistent with
the theoretical mass of acetylated edeine A. This reaction
product was unable to inhibit bacterial growth, unlike the un-
modified control (Figure 3A). Based on edeine’s mechanism
of action, the loss of growth inhibition should be due to loss
of the ability to inhibit translation. Therefore, in vitro translation
experiments were used to probe the effect of acetyledeine on
translation. Control GFP protein was translated in the absence
of drug, and was detected by fluorescence; the antibiotic
puromycin, a known ribosomal inhibitor, was used as a positive
control and stopped translation of GFP resulting in only back-
ground levels of fluorescence (Figure 3B). Edeine was observed
to completely abrogate translation in this system, but N-acety-
ledeine had no effect, even at 100 mg/ml (Figure 3B). Thus, the
addition of the acetyl group was sufficient to stop the inhibition
of protein synthesis, likely by blocking the ability of edeine to
bind the ribosome.
Edeine Resistance Conferred by Heterologous
Expression of EdeQ
Escherichia coli BL21(DE3) cells had a relatively high tolerance
to edeine, with a minimal inhibitory concentration (MIC) of
128 mg/ml for edeine A. Bacillus subtilis 168 cells were much
more sensitive, with an MIC of 16 mg/ml edeine A. When edeQ
was expressed in trans inB. subtilis 168, theMIC increased eightª2013 Elsevier Ltd All rights reserved 985
Figure 3. Characterization of EdeQ Activity
(A) Disk diffusion assay of edeine A after reaction with acetyl-CoA and EdeQ.
The lack of a zone of inhibition indicates that edeine A lost its activity against
B. subtilis 168 after the N-acetylation reaction.
(B) In vitro translation of control GFP by E. coli ribosomes, measured by GFP
fluorescence of reactions containing 100 mg/ml of selected antibacterial
agents.
See also Figure S1.
Figure 4. Structure of Edeine B1 Bound by the Ribosome
The guanylspermidine terminus (indicated) does not appear to make contacts
with the ribosome, but the DAPA residue (orange carbon backbone) is involved
in a turn structure that, if perturbed, may inhibit binding. The amino group of
DAPA that is N-aceytlated by EdeQ is indicated (black arrow). Adapted from
Protein Data Bank ID code 1I95 (Pioletti et al., 2001); the guanylspermidine
terminus was modified to reflect the structure of authentic edeine.
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edeQ confers increased resistance to edeine A in vivo.
Structural Analysis of N-Acetyledeine, the Inactivated
Edeine Form
The crystal structure of the 30S subunit of the Thermus
thermophilus ribosome in complex with edeine B shows that
the spermidine moiety does not form any contacts with the
ribosome (Figure 4; Pioletti et al., 2001). Instead, this portion
of the molecule extends away from the ribosome; this fact
seemed inconsistent with the initial predicted molecular basis
for the reversal of inhibition of translation due to acetylation of
the spermidine.
Edeine contains four primary amino groups (part of b-Tyr,
DAPA, DAHAA, or spermidine; Figure 1), all of which are
possible sites of N-acetylation. We therefore performed a
more detailed analysis of the regiospecificity of acetyltransfer
to edeine catalyzed by EdeQ. Tandem mass spectroscopy
(MS/MS) analysis generated positive ion fragments of m/z
797, 634, and 547 consistent with partial edeine structures
including an acetyl group (Figure 5). The next largest diagnostic
ion fragment was 419 m/z, consistent with the loss of both986 Chemistry & Biology 20, 983–990, August 22, 2013 ª2013 ElseviDAPA and the acetyl group. Theoretical ion fragments are
consistent with the absence of DAPA, but the presence of
the acetyl group (ie. 505.37 g/mol) was not observed (Fig-
ure S2). Therefore, the observed fragmentation pattern is
most consistent with a structure in which the acetyl group is
located on the primary amino group of the DAPA residue, not
the spermidine.
The location of the acetyl group was assessed with one-
dimensional and two-dimensional nuclear magnetic resonance
(NMR) analysis of high-pressure liquid chromatography (HPLC)-
purified N-acetyledeine A1. These spectra were compared with
those of authentic edeine A1. Complete NMR assignments
were reported (Table S2). The 1H NMR spectrum of N-acetyle-
deine A1 showed a resonance at 1.84 ppm (methyl group pro-
tons) that spin-coupled with a carbon resonance at 21.34 ppm;
these signalswere absent fromedeine A1 spectrum. Theposition
of the acetyl group was elucidated based on observation of an
upfield chemical shift of the a proton of DAPA by 0.33 ppm and
downfield shift of the b protons of DAPA (Figure 6). Heteronuclear
multiple bond correlation (HMBC) coupling interactions between
the methyl group protons (Figure 7B, a), DAPA protons (Figure
7B, b and c), and DAPA proton (Figure 7B, d) to the acetyl
carbonyl group at 173.8 ppmdemonstrated that the acetyl group
of N-acetyledeine A1 was located on the DAPA residue.
Interactions between the DAPA proton (Figure 7B, e) and DAPA
protons (Figure 7B, f) to the backbone carbonyl group at 169.7
ppm were also observed. The chemical shifts for the rest of the
molecule remained the same for edeine A1 and N-acetyledeine
A1, indicating that the only modification was the N-acetylation
of DAPA. Thus, it has been confirmed that the site of acetylation
is on the primary amino group of the DAPA residue.
The amino group of the DAPA residue of edeine A1 does
not appear to make contacts with the ribosome (Figure 4);er Ltd All rights reserved
Figure 5. MS/MS Fragmentation of Acetyledeine
Interpretation of observed masses from MS/MS fragmentation by correlating observed and expected mass. The location of fragmentation is indicated (dashed
lines) and corresponding masses are shown (below dashed lines).
See also Figure S2.
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structure that positions the b-Tyr, which makes several
binding contacts with the ribosome. The results of the in vivo
disk-diffusion assays and in vitro translation experiments
clearly demonstrate that the acetyl group of N-acetyledeine
A1 blocks ribosome interactions so that translation is not
inhibited.
Comparison of EdeQ Activity with Other Edeine Forms
The variety among the group of edeines produced by B. brevis
Vm4 provided useful tools to further probe the activity spectrum
of EdeQ. Having shown that the NMR result is consistent with
the regiospecific acetylation of the primary amino group of
DAPA in edeine A1, we utilized the inactive isomer, edeine A2,
where the amide bond is located at the b rather than a amino
group. Analysis of EdeQ reactions with a mixture of edeine A1
and edeine A2 demonstrate that edeine A2 is not a substrate
for EdeQ (Figure S1). This is likely because either the b amino
group of DAPA is inaccessible to EdeQ, or other changes to
the 3D structure of acetyledeine A1.
Edeine B is structurally similar to edeine A and differs only
in that it features a guanyl group attached to the spermidine ter-
minus of the molecule. EdeQ reactions using a mixture of edeine
B isomers B1 (active) and B2 (inactive) were analyzed with LC/
MS and an ion was observed with m/z = 840.48, consistent
with the expected mass of acetylated edeine B (data not shown).
Completed reactions were also tested for antimicrobial activity
as previously, using Kirby-Bauer disk-diffusion assays, and
demonstrated that N-acetyledeine B is inactive and does
not inhibit bacterial growth (data not shown). Loss of activity
suggests that the active edeine B1 was converted to
inactive acetyledeine B1, while edeine B2 remains unmodified.
This is as expected based on the activity pattern with
edeine A1 and A2 (Figure S1). Thus EdeQ eliminates the activity
of both active edeine types (edeine A1 and B1) produced by
B. brevis Vm4.
Conclusions
Edeine resistance has only been rarely documented in the
literature and not mechanistically explained. This prompted the
identification of the edeine biosynthesis cluster and discovery
of a gene, edeQ, which encoded edeine N-acetyltransferase,
which modifies the DAPA residue of active edeine isomers (iso-
mer 1; Figure 1).Chemistry & Biology 20, 98SIGNIFICANCE
The biosynthetic gene cluster for the production of edeines
has been identified in B. brevis Vm4. In the future, this will
enable studies of the biosynthesis of rare amino acid deriv-
atives found in edeines. In this study, a resistance enzyme,
EdeQ, was identified and is shown to confer resistance to
edeine A1 or edeine B1 via acetylation of the DAPA mono-
mer. The resulting N-acetyledeines are unable to inhibit
translation and therefore unable to inhibit bacterial growth,
demonstrating loss of antibiotic activity. This inactivation
scheme likely functions in addition to edeine efflux as a
method of self-resistance in the producing organism,
B. brevis Vm4. Work will continue in our laboratory to fully
describe the biosynthesis of edeines and to document the
potential for engineering analogs with improved activity
and therapeutic index.EXPERIMENTAL PROCEDURES
Strains, Culture Conditions, and Genome Sequencing
B. brevis Vm4 (ATCC 35690) was cultured at 30C in solid or liquid Peptone
Yeast extract (PY) media consisting of 1% (w/v) peptone, 0.5% yeast extract,
0.5% NaCl, 50 mg/ml MgCl2, and 30 mg/ml MnCl2, adjusted to pH 7.2. Kirby-
Bauer disk diffusion assays were performed on Mueller-Hinton Broth (MHB),
which was composed of 2.1% (w/v) MHB master mix, 25 mg/ml CaCl2, and
12.5 mg/ml MgCl2. For solid media, recipes were supplemented with 15 g/l
of agar.
The draft genome sequence of B. brevis Vm4 was obtained using
Roche 454 sequencing. B. brevis Vm4 genomic DNA was extracted with the
DNeasy Blood & Tissue Kit (QIAGEN) and sheared into approximately 1.5 kb
fragments using a Covaris S220 ultrasonicator (Covaris). Libraries were pre-
pared according to the XL+ Rapid Library Preparation Method manual (454
Life Sciences/Roche), and emulsion PCR and sequencing were performed
following the manufacturer’s instructions for the FLX+ instrument. De novo
assembly of the raw data was completed using MIRA version 3.4.0 (Chevreux
et al., 1999).Resistance Screening by Kirby-Bauer Disk Diffusion Assay
To test for activity of edeines, the Kirby-Bauer disk diffusion assay was used.
Bacillus subtilis 168 was diluted in sterile 0.85% (w/v) NaCl to an optical
density 600 (OD600) of 0.1, then spread evenly over the surface of an MHB
agar plate. Ten microliters of the drug or sample was micropipetted to the
center of a sterile filter disk pressed onto the agar. The plates were allowed
to dry for 5 min before they were incubated overnight at 30C. Zones of
inhibition indicted that edeines were active; absence of zones showed that
edeines were inactive.3–990, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 987
Figure 6. 1H-NMR Spectra
1H-NMR spectra of edeine A1 (red) and N-acetyl-
edeine A1 (blue).
See also Table S2.
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A 5 l culture of B. brevis Vm4 in PY medium was grown in a 7.5 l fermenter
(BioFlo/CelliGen 115 Benchtop Fermentor & Bioreactor; New Brunswick
Scientific) at 30C. The culture was agitated at 250 rpm and its pH was main-
tained at 7.0. After approximately 48 hr, the cells were separated from the
supernatant by centrifugation at 5180 3 g for 25 min at 4C (Avanti J-25;
Beckman Coulter). The latter was combined with 300 ml of SP Sepharose
XL (GE Healthcare) and stirred for 2 hr at 4C. The resin was then filtered
from the supernatant and washed with 1 l of distilled water. The pH of the
resulting mixture was adjusted to 9.0, after which the resin was packed into
a XK 50/20 column.
Using a fast protein liquid chromatography (FPLC) system (A¨KTAexplorer
100 Air; GE Healthcare), the column was washed with 2 l of distilled water,
then edeines were eluted with a 400 ml gradient of ammonium hydroxide
(0–0.5M). Fractions that showed absorbance at 272 nmwere tested for activity
against B. subtilis 168 using the Kirby-Bauer disk diffusion assay previously
described. The active fractions were pooled and lyophilized. The lyophilized
material was dissolved in 1ml of distilled water and applied to aMono S cation
exchange column (GE Healthcare) and eluted with a gradient of ammonium
formate (0–0.5 M). Eluted peaks were identified as edeines with LC/MS anal-
ysis (755 and 797 m/z, for edeine A and B, respectively). Separate pools of
edeine A and edeine B were lyophilized and stored at 4C.
Further purification of edeine A into individual isomers edeine A1 and edeine
A2was achieved using HPLC (Alliance HPLC;Waters). The lyophilizedmaterial
was dissolved in 200 ml of distilled water, and 20 ml of the sample were injected
onto a reverse-phase column (Inertsil ODS-4, 5 mm, 4.0 3 150 mm; GL
Sciences). Edeines were eluted at a flow rate of 0.5 ml/min using the following
acetonitrile gradient: 0%–30% over 25 min, 30% for 5 min, and 30%–100%
over 5 min; solvent A: 0.035% trifluoroacetic acid (TFA) in water; solvent B:
0.035% TFA in acetonitrile. The presence of edeines was monitored at
272 nm and only peaks that absorbed at this wavelength were collected.
Approximately 2 mg of each edeine A1 and edeine A2 were obtained from
7.5 l of spent media.
Cloning and Overexpression of edeQ
For overexpression in E. coli, the edeQ gene was amplified from B. brevis
Vm4 genomic DNA using primers that incorporate an NdeI and HindIII restric-
tion site upstream and downstream of the gene, respectively. The 50 ml PCR988 Chemistry & Biology 20, 983–990, August 22, 2013 ª2013 Elsevier Ltd All rights reservedreaction mixtures consisted of 13 Phusion HF
Buffer, 4.8% (v/v) dimethyl sulfoxide, 200 mM of
each dNTP, 0.5 mM of each primer, 150 ng of
template nucleic acid, and 0.02 U/ml of Phusion
DNA Polymerase (Fermentas). Reactions were
carried out in the following conditions: initial dena-
turation at 98C for 30 s, followed by 30 cycles of
10 s at 98C, 20 s at 60C, and 30 s at 72C,
followed by a final extension step of 10 min at
72C. The amplicons were purified and digested
withNdeI and HindIII, ligated with the correspond-
ingly digested pET-28a vector, and transformed
into E. coli TOP10. Once the results of molecular
cloning were verified by Sanger sequencing
(MOBIX Lab, McMaster University), the recom-
binant vectors were transformed into E. coli
BL21 (DE3). For expression in B. subtilis, the
edeQ gene was amplified as previously described
except that the primers incorporated EcoRI and
HindIII restriction sites, the annealing step was
30 s at 62C, and the plasmid was E. coli / B. sub-
tilis shuttle vector pRB374 (Bru¨ckner, 1992).Overexpression strains were grown in 1 l of LB supplemented with 50 mg/ml
of kanamycin at 37C with agitation (250 rpm). Once an OD600 of 0.6 had
been reached, overexpression was induced with 0.5 mM of isopropyl b-D-1-
thiogalactopyranoside (IPTG). Induction was allowed to continue for 3 hr at
37C before the cells were harvested by centrifugation at 3,315 rcf for
20 min at 4C. The pellet was washed with 50 mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid (HEPES) buffer (pH 7.5) and resuspended in buffer A
(pH 7.5, 50 mM HEPES, 100 mM NaCl, 10 mM imidazole, and 2% glycerol).
The cells were then lysed using a continuous flow cell disruptor (Constant
Systems) at 20,000 psi, and debris was removed by centrifugation at
48,000 3 g for 30 min at 4C.
The supernatant was loaded onto a HisTrap FF 5 ml column (GE Healthcare)
using an FPLC system (A¨KTApurifier 100; GE Healthcare) and eluted with a
step gradient of buffer B (pH 7.5, 50 mM HEPES, 100 mM NaCl, 500 mM
imidazole, and 2% glycerol). Step gradients of 5%, 30%, 50%, and 100% of
buffer B were used for the HisTrap column. Purified proteins were then
desalted using a HiPrep 26/10 desalting column to decrease the formation
of sodium adducts during mass spectrometry. Glycerol was added to all puri-
fied protein samples to a final concentration of 10% before storage at 20C.
In Vitro Enzyme Assays
The activity of EdeQ was tested in a 50 ml reaction containing 75mM of HEPES
(pH 7.5), 1 mM of acetyl-CoA, 0.4 mg/ml of edeine A, and 0.3 mg/ml of EdeQ.
BSA was substituted for EdeQ in the control condition and reactions were
incubated at 30C overnight. After the proteins were removed from the reac-
tionmixture using a spin column, the filtrate was analyzed using a disk diffusion
assay and LC/MS (AutoPurification System; Waters). The LC/MS was run at
1 ml/min on a Symmetry reverse-phase C18 column (3.5 mm, 4.6 3 75 mm;
Waters) using the following gradient: 0.0 min, 5% B; 0.5 min, 5% B; 7.5 min,
95% B; 8.5 min, 95% B; 9.0 min, 5% B; and 10.0 min, 5% B. Solvents A and
B were 0.1% TFA in water and 0.1% TFA in acetonitrile, respectively.
In vitro translation reactions were carried out using the PURExpress in vitro
protein synthesis kit as per the manufacturer’s instructions (New England
Biolabs, Ipswich, MA) with slight modifications. In brief, the kit allows the
cell-free synthesis of green fluorescence protein. For the purposes of
testing edeines, detection of fluorescent signal indicates that transcription
and translation are occurring. The absence of a fluorescent signal demon-
strates that the compound added (edeine, N-acetyledeine, or puromycin) is
Figure 7. Selected HMBC Couplings of N-
Acetyledeine A1
(A) Structural diagram of DAPA residue depicting
key HMBC couplings.
(B) HMBC spectra showing couplings between
DAPA or methyl group protons and acetyl carbonyl
group (a–d) and between DAPA protons and the
backbone carbonyl group (e and f). Observations
confirm that the site of acetylation is the DAPA
residue (see text for more details).
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Edeine Self-Resistance by N-Acetylationinhibiting protein synthesis. Drugs were added to a final concentration of
100 mg/ml to individual reactions and pre-incubated for 15 min at 37C before
the addition of the plasmid template.
Mass Spectrometry andNuclearMagnetic Resonance Spectroscopy
Analyses
High-resolution mass spectra were obtained using ThermoFisher-XL-Orbitrap
Hybrid mass spectrometer (Thermo-Fisher, Bremen, Germany) equipped with
electrospray interface operated in positive and negative ion modes. One- and
two-dimensional NMR experiments were performed using a Bruker AVIII 700
MHz instrument equipped with a cryoprobe in D20. Chemical shifts are re-
ported in parts per million relative to tetramethylsilane using the residual sol-
vent signal at 4.65 ppm as an internal standard.
SUPPLEMENTAL INFORMATION
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